Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Treatment of Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03403101
What this trial is testing

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
Fudan University 65
Early research (Phase 1)UnknownNCT02278458
What this trial is testing

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Betta Pharmaceuticals Co., Ltd. 24
Testing effectiveness (Phase 2)UnknownNCT02124317
What this trial is testing

Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Chinese PLA General Hospital 60
Not applicableLooking for participantsNCT07407231
What this trial is testing

Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)

Who this might be right for
Locally Advanced Pancreatic Cancer
Institute of Oncology Ljubljana 18
Post-approval studies (Phase 4)Ended earlyNCT00642733
What this trial is testing

First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 6
Post-approval studies (Phase 4)UnknownNCT04217096
What this trial is testing

Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients

Who this might be right for
Advanced Pancreatic Cancer
Fudan University 40
Testing effectiveness (Phase 2)UnknownNCT03963193
What this trial is testing

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Who this might be right for
Gastrointestinal Neuroendocrine Tumor
Henan Cancer Hospital 112
Testing effectiveness (Phase 2)UnknownNCT04447092
What this trial is testing

Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy Effect
Seoul National University Hospital 77
Not applicableUnknownNCT03768687
What this trial is testing

A Real-world Study of Albumin-bound Paclitaxel in the Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 300
Large-scale testing (Phase 3)Study completedNCT00051467
What this trial is testing

TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GenVec
Testing effectiveness (Phase 2)Study completedNCT02043730
What this trial is testing

Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer Stage II
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 124
Testing effectiveness (Phase 2)Study completedNCT03415802
What this trial is testing

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Aiping Zhou 32
Testing effectiveness (Phase 2)Study completedNCT03264404
What this trial is testing

Azacitidine and Pembrolizumab in Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Susan E. Bates 36
Early research (Phase 1)Active Not RecruitingNCT05411094
What this trial is testing

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)UnknownNCT02135822
What this trial is testing

Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Temporarily pausedNCT05494697
What this trial is testing

Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC

Who this might be right for
Pancreatic Cancer
AIM ImmunoTech Inc. 90
Testing effectiveness (Phase 2)Study completedNCT04624217
What this trial is testing

A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 56
Large-scale testing (Phase 3)Looking for participantsNCT07079228
What this trial is testing

Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Qilu Pharmaceutical Co., Ltd. 602
Testing effectiveness (Phase 2)Looking for participantsNCT05859750
What this trial is testing

AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Akeso 78
Large-scale testing (Phase 3)Looking for participantsNCT07232875
What this trial is testing

HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer

Who this might be right for
KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
Jiangsu HengRui Medicine Co., Ltd. 588
Next Page